| scholarly article | Q13442814 |
| P2093 | author name string | Ali Haydar | |
| Ali Shamseddine | |||
| Peter Allen | |||
| Ghassan K Abou-Alfa | |||
| Leonard B Saltz | |||
| Mohamed Khalife | |||
| Walid Faraj | |||
| Eileen M O'Reilly | |||
| David P Kelsen | |||
| Alexandra Snyder | |||
| Sally Temraz | |||
| Fadi El-Merhi | |||
| Ashwaq El-Olayan | |||
| Mohamed Naghy | |||
| Mohamed Eloubeidi | |||
| P2860 | cites work | The diagnosis of pancreatic cancer by endoscopic ultrasonography | Q68130209 |
| Endoscopic ultrasonography in diagnosis and staging of pancreatic cancer | Q72642803 | ||
| Endoscopic ultrasound criteria for vascular invasion in the staging of cancer of the head of the pancreas: a blind reevaluation of videotapes | Q73053101 | ||
| High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families | Q74098963 | ||
| Prognostic value of microsatellite instability in resectable pancreatic cancer | Q74597414 | ||
| BRCA2 germline mutations in familial pancreatic carcinoma | Q78891021 | ||
| Effect of neoadjuvant chemoradiation and surgical technique on recurrence of localized pancreatic cancer | Q82417813 | ||
| Preoperative biliary drainage for cancer of the head of the pancreas | Q82495675 | ||
| Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene | Q24658271 | ||
| Risk of pancreatic adenocarcinoma in patients with hereditary pancreatitis: a national exhaustive series | Q28264132 | ||
| FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer | Q29547638 | ||
| Importance of age of onset in pancreatic cancer kindreds | Q33598358 | ||
| Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial | Q33686700 | ||
| Multimodality therapy offers a chance for cure in patients with pancreatic adenocarcinoma deemed unresectable at first operative exploration | Q33860986 | ||
| Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer | Q33983094 | ||
| A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers. | Q34335982 | ||
| Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis | Q34378109 | ||
| Cancer risks in BRCA2 mutation carriers | Q34504452 | ||
| Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group | Q34506417 | ||
| Very high risk of cancer in familial Peutz-Jeghers syndrome | Q34512286 | ||
| Cancer Incidence in BRCA1 mutation carriers | Q34527264 | ||
| A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer | Q34546440 | ||
| Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection | Q34695255 | ||
| Molecular diagnosis of early pancreatic ductal adenocarcinoma in high-risk patients. | Q34743089 | ||
| Lymph-node ratio is an independent prognostic factor in patients with stage III colorectal cancer: a retrospective study from the Middle East | Q36168084 | ||
| Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review | Q36468523 | ||
| Are racial disparities in pancreatic cancer explained by smoking and overweight/obesity? | Q36779234 | ||
| ATM mutations in patients with hereditary pancreatic cancer | Q36913473 | ||
| ABO blood group and the risk of pancreatic cancer | Q37131928 | ||
| Chemoradiotherapy in the management of locally advanced pancreatic carcinoma: a qualitative systematic review | Q37421104 | ||
| Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement | Q37456389 | ||
| Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement | Q37460990 | ||
| Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial | Q38391782 | ||
| Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review | Q41127594 | ||
| Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial | Q43804989 | ||
| A prospective study of cigarette smoking and the risk of pancreatic cancer | Q44016720 | ||
| Gene-environment interaction in hereditary nonpolyposis colorectal cancer with implications for diagnosis and genetic testing. | Q44745628 | ||
| Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head | Q46473461 | ||
| Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. | Q53627046 | ||
| Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. | Q54976011 | ||
| A Familial Syndrome of Pancreatic Cancer and Melanoma with a Mutation in theCDKN2Tumor-Suppressor Gene | Q55670980 | ||
| Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies | Q57758319 | ||
| Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion ofp16 (p16-Leiden) | Q57948729 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 169-173 | |
| P577 | publication date | 2012-09-01 | |
| P1433 | published in | Gastrointestinal cancer research : GCR | Q27722152 |
| P1476 | title | Neoadjuvant Therapy in Clinical Stage II Pancreatic Adenocarcinoma | |
| P478 | volume | 5 |
Search more.